Past News

The Pharmacopoeial Discussion Group (PDG), which brings together the European Pharmacopoeia, the Japanese Pharmacopoeia and the United States Pharmacopeia, held its annual autumn meeting via videoconference on 22-23 September 2020, with WHO attending as observer. Due to the COVID-19 pandemic, the face-to-face meeting originally scheduled was reorganised as a videoconference devoted entirely to...

The Committee of Ministers of the Council of Europe has adopted a recommendation calling on member states to take measures to protect the health of donors of haematopoietic progenitor cells (HPCs). These cells are used as a lifesaving treatment for patients with severe blood diseases and are the most frequently donated cells for transplantation.

The EDQM announces the availability of 10 new reference standards and 22 replacement batches, released in September 2020

The European Pharmacopoeia (Ph. Eur.) Supplement 10.4 is now available and will be applicable in 39 European countries as of 1 April 2021.

As health systems worldwide continue to cope with the impact of the COVID-19 pandemic, the EDQM/Council of Europe publishes this year’s issue of the Newsletter Transplant. The timely release of this issue is proof of the EDQM’s dedication to the international medical community and all those involved in the preparation of this publication.

At its 167th session in June 2020, the European Pharmacopoeia Commission adopted revised dosage form monographs on transdermal patches, cutaneous patches and medicated plasters, as well as the related test method for dissolution testing.

The EDQM/Council of Europe will implement the “Reorganisation of the Romanian Blood System” project. The project aims to support Romania in setting up a fit-for-purpose and efficient blood transfusion system aligned with European Union and EDQM standards. The EDQM is therefore seeking experienced professionals in the field of blood transfusion to provide consultancy services in order to: develop...